Sarah J Billups, Ashley Daffron, Christopher Harty, Lisa M Schilling, Rachel N Lowe, Ingrid Lobo
{"title":"Centralized outreach with embedded pharmacist e-consultation to reduce therapeutic inertia and improve blood pressure control.","authors":"Sarah J Billups, Ashley Daffron, Christopher Harty, Lisa M Schilling, Rachel N Lowe, Ingrid Lobo","doi":"10.1093/ajhp/zxaf096","DOIUrl":null,"url":null,"abstract":"<p><strong>Disclaimer: </strong>In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.</p><p><strong>Purpose: </strong>To evaluate the impact of a population health intervention to reduce therapeutic inertia and improve hypertension control in a multipractice primary care setting.</p><p><strong>Methods: </strong>This retrospective cohort study compares clinical and process outcomes in an intervention cohort versus a parallel comparator cohort of patients in nonintervention clinics. Centralized outreach coordinators identified patients with systolic blood pressure (BP) of >150 mm Hg, called each patient, scheduled a hypertension-focused visit with a primary care physician (PCP), then forwarded a message to the clinic-based pharmacist, who reviewed the patient record and documented clinical recommendations for hypertension control prior to the patient visit.</p><p><strong>Results: </strong>Outreach was performed for 426 intervention patients from July to December 2022, and outcomes were compared to those in 587 usual-care patients. A higher percentage of intervention patients attended a hypertension-focused clinic visit with their PCP (57.3% vs 38.8%, adjusted P < 0.001), had hypertensive therapy addressed at that visit when their BP was above 140/90 mm Hg (63.3% vs 44.2%, adjusted P = 0.010), and achieved a BP of <140/90 mm Hg (27.9% vs 16.9%, adjusted P < 0.001) within 6 months of outreach.</p><p><strong>Conclusion: </strong>A clinic-based population health approach reduced therapeutic inertia and improved BP control in a cohort of in hypertensive patients compared with a similar cohort of patients in clinics who did not receive the intervention.</p>","PeriodicalId":7577,"journal":{"name":"American Journal of Health-System Pharmacy","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Health-System Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajhp/zxaf096","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
Purpose: To evaluate the impact of a population health intervention to reduce therapeutic inertia and improve hypertension control in a multipractice primary care setting.
Methods: This retrospective cohort study compares clinical and process outcomes in an intervention cohort versus a parallel comparator cohort of patients in nonintervention clinics. Centralized outreach coordinators identified patients with systolic blood pressure (BP) of >150 mm Hg, called each patient, scheduled a hypertension-focused visit with a primary care physician (PCP), then forwarded a message to the clinic-based pharmacist, who reviewed the patient record and documented clinical recommendations for hypertension control prior to the patient visit.
Results: Outreach was performed for 426 intervention patients from July to December 2022, and outcomes were compared to those in 587 usual-care patients. A higher percentage of intervention patients attended a hypertension-focused clinic visit with their PCP (57.3% vs 38.8%, adjusted P < 0.001), had hypertensive therapy addressed at that visit when their BP was above 140/90 mm Hg (63.3% vs 44.2%, adjusted P = 0.010), and achieved a BP of <140/90 mm Hg (27.9% vs 16.9%, adjusted P < 0.001) within 6 months of outreach.
Conclusion: A clinic-based population health approach reduced therapeutic inertia and improved BP control in a cohort of in hypertensive patients compared with a similar cohort of patients in clinics who did not receive the intervention.
免责声明:为了加快文章的发表,AJHP在接受稿件后将尽快在网上发布。被接受的稿件已经过同行评审和编辑,但在技术格式化和作者校对之前会在网上发布。这些手稿不是记录的最终版本,稍后将被最终文章(按照AJHP风格格式化并由作者校对)所取代。目的:评估人群健康干预对减少治疗惰性和改善高血压控制在多诊所初级保健设置的影响。方法:这项回顾性队列研究比较了干预队列与非干预诊所患者的平行比较队列的临床和过程结果。集中外展协调员确定收缩压(BP)为bb0 - 150毫米汞柱的患者,给每位患者打电话,安排与初级保健医生(PCP)进行以高血压为重点的就诊,然后将信息转发给临床药剂师,药剂师在患者就诊前审查患者记录并记录高血压控制的临床建议。结果:2022年7月至12月,对426例干预患者进行了外展,并将结果与587例常规护理患者进行了比较。更高比例的干预患者带着他们的PCP参加了以高血压为重点的门诊就诊(57.3% vs 38.8%,校正P < 0.001),当他们的血压高于140/90 mm Hg时接受了高血压治疗(63.3% vs 44.2%,校正P = 0.010),并且血压达到了在一组高血压患者中,以临床为基础的人群健康方法与未接受干预的类似临床队列患者相比,减少了治疗惰性,改善了血压控制。
期刊介绍:
The American Journal of Health-System Pharmacy (AJHP) is the official publication of the American Society of Health-System Pharmacists (ASHP). It publishes peer-reviewed scientific papers on contemporary drug therapy and pharmacy practice innovations in hospitals and health systems. With a circulation of more than 43,000, AJHP is the most widely recognized and respected clinical pharmacy journal in the world.